Is Lumexa Imaging Holdings going out of business?

Lumexa Imaging Holdings, Inc. (LMRI) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

Lumexa Imaging Holdings, Inc. (LMRI) scores 30 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Leading signal: Shares dilution YoY: 38.06% (YoY)

Five questions, kept separate

Survival - Funding dependent

50+ mo of estimated runway from 2026-06-30, based on $69.7M of cash and short-term investments against $14.1M of annual burn. Adjusted shares outstanding increased 38.1% over the comparison year.

Business quality - Weak

9.4% operating margin and -1.4% FCF margin produce a weak Business Quality assessment.

Trajectory - Clinical progress unavailable

Fundamentals can show funding and burn, but not whether the clinical pipeline is advancing.

Valuation - Extreme expectations

-1.3% FCF yield supports an extreme expectations Valuation assessment on the ttm basis.

Event risk - Evidence unavailable

No active asserted adverse event was found in the available filing evidence. The filing evidence is stale or incomplete, so this is not proof of absence.

What the rules read

• Debt / Equity: 1.61x
• Shares dilution YoY: 38.06% (YoY)
• Return on Assets: -0.58%
• ROIC: 3.13%
• Interest coverage: 1.0x
• Cash Runway (years): 4.95y
• Debt Maturity Runway: 98% long-term (Long-term focused)
• Revenue growth YoY: 5.08% (YoY)
• FCF margin: -1.39% (Inv. Mode)
• Cash Burn Deceleration: 8.80% QoQ improvement
• Price / Sales: 1.1x (see Valuation)
• Price / Earnings: Unprofitable (see Valuation)

Read from filings through 2026-08-13.

Price as of 2026-09-07.